180 "/0.5 "

: Pegasys 180 Mcg/0.5 Ml. ?  »
|
-

S.C

Solution For Injection

Chronic Hepatitis B: Pegasys is indicated for the treatment of both HBeAg- positive and HBeAg -negative chronic hepatitis B in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.Chronic Hepatitis C: Pegasys is indicated for the treatment of chronic hepatitis C in adult patients who are positive for serum HCV-RNA including patients with compensated cirrhosis and/or co-infected with clinically stable HIV. The optimal way to use Pegasys in patients with chronic hepatitis C is in combination with ribavirin. The combination of Pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. Monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.

129 11 30805 00

Hoffmann La Roche Ltd, Switzerland

09/2013 - 09/2023

.
, .
.
/
Peginterferon alfa 2a 180 MCG / 0.5 ML
Pre filled pen glass type i 1 x 24
Pre filled pen glass type i 4 x 24
Syringe prefilled glass type i 1 x 36
Syringe prefilled glass type i 4 x 36

*

*

 

.

 
" !
 

, .
:  »
101
( ) , -